๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cosmetic camouflage advice improves quality of life

โœ Scribed by S.A. Holme; P.E. Beattie; C.J. Fleming


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
53 KB
Volume
147
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

The subjective benefit of attendance at cosmetic clinics has not previously been reported.

Objectives:

To assess the effect on perceived quality of life (qol) of cosmetic camouflage advice.

Methods:

In a three-centre study, 135 individuals were invited to complete a dermatology-specific qol measure, the dermatology life quality index (dlqi), before and 1 month after their first visit to a cosmetic camouflage clinic.

Results:

Eighty-two completed dlqi questionnaires were returned before the camouflage clinic appointment, and 56 corresponding questionnaires were returned 1 month after. the mean age of responders was 50 years, and the mean duration of their skin conditions was 15 years. the main conditions seen were pigmentary disorders (29%), scars (22%) and vascular disorders (13%). there was a significant difference in mean dlqi scores before and after the clinic visit (9.1 vs. 5.8, p = 0.0001).

Conclusions:

When assessed at 1 month, attendance at a cosmetic camouflage clinic appears to improve qol significantly.


๐Ÿ“œ SIMILAR VOLUMES


Improving the quality and life of sagger
โœ I. M. Berdichevskii; M. B. Borisov; O. N. Toropova; T. A. Pashkova; V. I. Soroki ๐Ÿ“‚ Article ๐Ÿ“… 1974 ๐Ÿ› Springer US ๐ŸŒ English โš– 241 KB
Rasagiline improves quality of life in p
โœ Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB ๐Ÿ‘ 1 views

The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P